Personensuche
Personensuche
Es wurde 1 Person gefunden.
Telefon
Funktionen
-
Direktor/in, Klinik für Frauenheilkunde und Geburtshilfe
Aktuelle Veranstaltungen
-
SoSe 2025
- Anamnese Seminar für Blockpraktikanten (8. FS PV)
- Frauenheilkunde und Geburtshilfe (7. FS WA) (3. Semester des zweiten Studienabschnittes)
- Frauenheilkunde und Geburtshilfe (8. FS PV) (4. Semester des zweiten Studienabschnittes)
- Wahlfach: Praxis der gynäkologischen und geburtshilflichen Diagnostik (*)
- Gynäkologisches Seminar für Blockpraktikanten (PV)
- Seminar Geburtshilfe für Blockpraktikanten (8. FS PV)
Vergangene Veranstaltungen (max. 10)
-
WiSe 2024
- Frauenheilkunde und Geburtshilfe (8. FS PV) (4. Semester des zweiten Studienabschnittes)
- Frauenheilkunde und Geburtshilfe (7. FS WA) (3. Semester des zweiten Studienabschnittes)
- Anamnese Seminar für Blockpraktikanten (8. FS PV)
- Seminar Geburtshilfe für Blockpraktikanten (8. FS PV)
- Gynäkologisches Seminar für Blockpraktikanten (PV)
- Wahlfach: Praxis der gynäkologischen und geburtshilflichen Diagnostik (*)
-
SoSe 2024
- Frauenheilkunde und Geburtshilfe (7. FS WA) (3. Semester des zweiten Studienabschnittes)
- Anamnese Seminar für Blockpraktikanten (8. FS PV)
- Frauenheilkunde und Geburtshilfe (8. FS PV) (4. Semester des zweiten Studienabschnittes)
- Wahlfach: Praxis der gynäkologischen und geburtshilflichen Diagnostik (*)
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Cancer-field surgery for endometrial cancer by robotic peritoneal mesometrial resection and targeted compartmental lymphadenectomy (PMMR+TCL)In: Journal of Gynecologic Oncology , Jg. 36 2025, Nr. 1, e13DOI, Online Volltext (Open Access)
-
Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligenceIn: Nature Cancer , Jg. 6 2025, Nr. 2, S. 307 – 322DOI (Open Access)
-
Giant Uterine Leiomyoma Causing Severe Hemodynamic InstabilityIn: O&G Open , Jg. 2 2025, Nr. 1, e059DOI (Open Access)
-
Outcomes of low-risk endometrial cancer with isolated tumor cells in the sentinel lymph nodes : a prospective, multi-center, single-arm, observational study (ENDO-ITC study)In: International Journal of Gynecological Cancer 2025, 101764
-
Robotic Minimally-Invasive Staging in Early Stage Ovarian Cancer and Borderline TumorsIn: Journal of Gynecologic Surgery , Jg. 41 2025, Nr. 1, S. 43 – 48
-
The role of molecular classification in endometrial cancer : a focus on patients with low-volume metastasis—a retrospective multi-center study and literature reviewIn: International Journal of Gynecological Cancer , Jg. 35 2025, Nr. 6, 101912
-
Thymidine kinase 1 concentration and activity in metastatic breast cancer under CDK4/6 inhibitor therapyIn: Scientific Reports , Jg. 15 2025, Nr. 1, 10347DOI (Open Access)
-
Alteration in sB7-H4 Serum Levels and Placental Biomarker Expression after Therapeutic Plasma Exchange in Early-Onset Preeclampsia PatientsIn: International Journal of Molecular Sciences (IJMS) , Jg. 25 2024, Nr. 20, 11082DOI (Open Access)
-
CCN1-Mediated Signaling in Placental Villous Tissues after SARS-CoV-2 Infection in Term Pregnant Women : Implications for Dysregulated AngiogenesisIn: Current Issues in Molecular Biology , Jg. 46 2024, Nr. 4, S. 3533 – 3550DOI, Online Volltext (Open Access)
-
Chest wall resections for advanced breast cancer : a narrative reviewIn: Journal of Thoracic Disease , Jg. 16 2024, Nr. 10, S. 7182 – 7191DOI (Open Access)
-
Corrigendum : Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascitesIn: Frontiers in Immunology , Jg. 15 2024, 1420991DOI (Open Access)
-
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual diseaseIn: npj Genomic Medicine , Jg. 9 2024, Nr. 1, 19DOI (Open Access)
-
High serum levels of leucine-rich α-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancerIn: Archives of Gynecology and Obstetrics , Jg. 309 2024, Nr. 6, S. 2789 – 2798DOI (Open Access)
-
Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascitesIn: Frontiers in Immunology , Jg. 15 2024, 1360615DOI, Online Volltext (Open Access)
-
Impact of 2 years of COVID-19 pandemic on preterm birth : Experience from a tertiary center of obstetrics in western GermanyIn: International Journal of Gynecology & Obstetrics , Jg. 166 2024, Nr. 1, S. 404 – 411DOI (Open Access)
-
Impact of the Immunomodulatory Factor Soluble B7-H4 in the Progress of Preeclampsia by Inhibiting Essential Functions of Extravillous Trophoblast CellsIn: Cells , Jg. 13 2024, Nr. 16, 1372DOI, Online Volltext (Open Access)
-
Krebsfeldchirurgie des Endometriumkarzinoms : Ergebnisse zur peritonealen mesometrialen Resektion plus „targeted compartmental lymphadenectomy“In: Die Gynäkologie , Jg. 57 2024, Nr. 5, S. 325 – 331
-
Overexpression of Human sFLT1 in the Spongiotrophoblast Is Sufficient to Induce Placental Dysfunction and Fetal Growth Restriction in Transgenic MiceIn: International Journal of Molecular Sciences (IJMS) , Jg. 25 2024, Nr. 4, 2040DOI, Online Volltext (Open Access)
-
Peritoneal mesometrial resection with lymphadenectomy following prior hysterectomy in intermediate/high-risk endometrial cancer : feasibility and safetyIn: Archives of Gynecology and Obstetrics 2024 , in pressDOI (Open Access)
-
Primary results of the AGO-Zervix-1 Study : A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancerIn: Gynecologic Oncology , Jg. 183 2024, S. 25 – 32DOI (Open Access)
-
Retrotransposons are co-opted to activate hematopoietic stem cells and erythropoiesisIn: Science , Jg. 386 2024, Nr. 6722, eado6836
-
Sentinel Lymph node detection in endometrial cancer : Anatomical and scientific factsIn: Best Practice and Research Clinical Obstetrics and Gynaecology , Jg. 94 2024, 102483DOI (Open Access)
-
The Importance of Vaccination, Variants and Time Point of SARS-CoV-2 Infection in Pregnancy for Stillbirth and Preterm Birth Risk : An Analysis of the CRONOS Register StudyIn: Journal of Clinical Medicine (JCM) , Jg. 13 2024, Nr. 6, 1522DOI (Open Access)
-
Cervical ectopic pregnancy : the first case of live birth and uterus-conserving managementIn: BMC Pregnancy and Childbirth , Jg. 23 2023, 664DOI, Online Volltext (Open Access)
-
Electrolyte imbalance causes suppression of NK and T cell effector function in malignant ascitesIn: Journal of Experimental & Clinical Cancer Research , Jg. 42 2023, Nr. 1, 235DOI, Online Volltext (Open Access)
-
Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patientsIn: Frontiers in Immunology , Jg. 14 2023, 1188030DOI, Online Volltext (Open Access)
-
Growth-Restricted Fetuses and Offspring Reveal Adverse Sex-Specific Metabolic Responses in Preeclamptic Mice Expressing Human sFLT1In: International Journal of Molecular Sciences (IJMS) , Jg. 24 2023, Nr. 8, 6885DOI, Online Volltext (Open Access)
-
Hysterectomy in benign conditions : A 20-year single-center retrospective on the development of surgical techniquesIn: Archives of Gynecology and Obstetrics , Jg. 307 2023, Nr. 3, S. 807 – 812DOI (Open Access)
-
Hysterektomie im Wandel der Zeit : Retrospektive Analyse der operativen Techniken in den letzten 20 Jahren an der Universitätsfrauenklinik EssenIn: Die Gynäkologie , Jg. 56 2023, Nr. 2, S. 127 – 131
-
Multiple Parasitic Myomas in the Pelvis–Treatment by Robotic AccessIn: Journal of Minimally Invasive Gynecology (JMIG) , Jg. 30 2023, Nr. 5, S. 353 – 354
-
New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung MetastasesIn: Cancers , Jg. 15 2023, Nr. 17, 4355DOI, Online Volltext (Open Access)
-
Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapseIn: Journal of Cancer Research and Clinical Oncology , Jg. 149 2023, Nr. 3, S. 1159 – 1174DOI (Open Access)
-
Ratios of monocytes and neutrophils to lymphocytes in the blood predict benefit of CDK4/6 inhibitor treatment in metastatic breast cancerIn: Scientific Reports , Jg. 13 2023, Nr. 1, 21262DOI, Online Volltext (Open Access)
-
The Diversity of Liquid Biopsies and Their Potential in Breast Cancer ManagementIn: Cancers , Jg. 15 2023, Nr. 22, 5463DOI (Open Access)
-
Therapeutic Plasma Exchange in Early-Onset Preeclampsia : A 7-Year Monocentric ExperienceIn: Journal of Clinical Medicine (JCM) , Jg. 12 2023, Nr. 13, 4289DOI (Open Access)
-
Uterine Nische: geburtshilfliche und gynäkologische Folgen : Was sollen wir über diese zunehmend häufige Diagnose wissen und wie sollten wir Patientinnen beraten?In: Die Gynäkologie , Jg. 56 2023, Nr. 5, S. 359 – 363
-
Von der Mastitis zum Multiorganversagen : Ein seltenes, potenziell tödliches ProblemIn: Die Gynäkologie , Jg. 56 2023, Nr. 1, S. 58 – 61DOI (Open Access)
-
Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A₁₆₅b, an Antiangiogenic VEGF-A Splice VariantIn: Clinical Cancer Research , Jg. 28 2022, Nr. 21, S. 4660 – 4668
-
CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian CancerIn: Frontiers in Oncology , Jg. 12 2022, 798680DOI, Online Volltext (Open Access)
-
COVID-19 - Auswirkungen der Pandemie auf Behandlungsgeschehen und ErlössituationIn: Geburtshilfe und Frauenheilkunde , Jg. 82 2022, Nr. 9, S. 909 – 911
-
Combinatorial Power of cfDNA, CTCs and EVs in OncologyIn: Diagnostics , Jg. 12 2022, Nr. 4, S. 870DOI, Online Volltext (Open Access)
-
Complications and satisfaction in transwomen receiving breast augmentation : short- and long-term outcomesIn: Archives of Gynecology and Obstetrics , Jg. 305 2022, Nr. 6, S. 1517 – 1524DOI (Open Access)
-
Course of the sFlt-1/PlGF ratio in fetal growth restriction and correlation with biometric measurements, feto-maternal Doppler parameters and time to deliveryIn: Archives of Gynecology and Obstetrics , Jg. 305 2022, Nr. 3, S. 597 – 605DOI (Open Access)
-
Die Mammareduktionsplastik – doch mehr als eine rein plastische Operation? : Ergebnisse einer Studie an der Frauenklinik des Universitätsklinikums EssenIn: Die Gynäkologie , Jg. 55 2022, Nr. 9, S. 690 – 701DOI (Open Access)
-
Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer : A Subgroup Analysis of AGO OVAR 12 TrialIn: Cancers , Jg. 14 2022, Nr. 5, 1189DOI (Open Access)
-
In Early Breast Cancer, the Ratios of Neutrophils, Platelets and Monocytes to Lymphocytes Significantly Correlate with the Presence of Subsets of Circulating Tumor Cells but Not with Disseminated Tumor CellsIn: Cancers , Jg. 14 2022, Nr. 14, 3299DOI, Online Volltext (Open Access)
-
Kommentar zu: Neue Aspekte in Diagnostik und Therapie des EndometriumkarzinomsIn: Der Gynäkologe , Jg. 55 2022, Nr. 3, S. 215 – 216
-
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World SettingIn: International Journal of Molecular Sciences (IJMS) , Jg. 23 2022, Nr. 15, 8716DOI (Open Access)
-
Multimodality in liquid biopsy : does a combination uncover insights undetectable in individual blood analytes?In: Journal of Laboratory Medicine , Jg. 46 2022, Nr. 4, S. 255 – 264DOI (Open Access)
-
Ovarian cancer surgery in Germany : An analysis of the nationwide hospital file 2005-2015In: Women's Health , Jg. 18 2022, 17455065221075903DOI, Online Volltext (Open Access)
-
Prediction of Short and Long Survival after Surgery for Breast Cancer Brain MetastasesIn: Cancers , Jg. 14 2022, Nr. 6, 1437DOI, Online Volltext (Open Access)
-
Radiographic markers of breast cancer brain metastases : relation to clinical characteristics and postoperative outcomeIn: Acta Neurochirurgica , Jg. 164 2022, S. 439 – 449DOI (Open Access)
-
Sensitivity and specificity of loss of heterozygosity analysis for the classification of rare germline variants in BRCA1/2 : Results of the observational AGO-TR1 study (NCT02222883)In: Journal of Medical Genetics (eJMG) , Jg. 59 2022, S. 248 – 252DOI (Open Access)
-
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflowIn: Breast Cancer: The Journal of the Japanese Breast Cancer Society , Jg. 29 2022, Nr. 3, S. 487 – 497DOI (Open Access)
-
Single-center study for robotic-assisted laparoscopic sacropexies : A one-fits-all strategy for pelvic organ prolapse?In: Archives of Gynecology and Obstetrics , Jg. 306 2022, Nr. 6, S. 2009 – 2015DOI (Open Access)
-
Soluble PD-L1 and B7-H4 serum levels during the course of physiological pregnancyIn: American Journal of Reproductive Immunology , Jg. 87 2022, Nr. 3, e13519DOI (Open Access)
-
Soluble endoglin versus sFlt-1/PlGF ratio : Detection of preeclampsia, HELLP syndrome, and FGR in a high-risk cohortIn: Hypertension in Pregnancy , Jg. 41 2022, Nr. 3-4, S. 159 – 172
-
Systematic Evaluation of HLA-G 3’Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients : UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease OutcomeIn: Frontiers in Immunology , Jg. 12 2022, 817132DOI, Online Volltext (Open Access)
-
Systemic Maternal Human sFLT1 Overexpression Leads to an Impaired Foetal Brain Development of Growth-Restricted Foetuses upon Experimental PreeclampsiaIn: Oxidative Medicine and Cellular Longevity , Jg. 2022 2022, 3024032DOI, Online Volltext (Open Access)
-
The immunological role of B7-H4 in pregnant women with Sars-Cov2 infectionIn: American Journal of Reproductive Immunology , Jg. 88 2022, Nr. 6, e13626DOI (Open Access)
-
Time interval between the diagnosis of breast cancer and brain metastases impacts prognosis after metastasis surgeryIn: Journal of Neuro-Oncology , Jg. 159 2022, Nr. 1, S. 53 – 63DOI (Open Access)
-
Total mesometrial resection (TMMR) for cervical cancer FIGO IB–IIA : First results from the multicentric TMMR register studyIn: Journal of Gynecologic Oncology , Jg. 33 2022, Nr. 1, e9DOI (Open Access)
-
Totale mesometriale Resektion (TMMR) + therapeutische Lymphonodektomie (tLNE) beim Zervixkarzinom FIGO IB – IIAIIA : Erste Ergebnisse der multizentrischen TMMR-RegisterstudieIn: Der Gynäkologe , Jg. 55 2022, Nr. 2, S. 114 – 121
-
70/w mit Postmenopausenblutung : Vorbereitung auf die Facharztprüfung: Fall 45In: Der Gynäkologe , Jg. 54 2021, S. 101 – 105
-
Abnormal expression of the costimulatory molecule B7‐H4 in placental chorionic villous and decidual basalis tissues of patients with preeclampsia and HELLP syndromeIn: American Journal of Reproductive Immunology , Jg. 86 2021, Nr. 3, e13430DOI (Open Access)
-
Accuracy of ultrasonography and magnetic resonance imaging for preoperative staging of cervical cancer : analysis of patients from the prospective study on total mesometrial resectionIn: Diagnostics , Jg. 11 2021, Nr. 10, 1749DOI (Open Access)
-
An observational study on breast cancer survival and lifestyle related risk factorsIn: In Vivo , Jg. 35 2021, Nr. 2, S. 1007 – 1015DOI (Open Access)
-
Association of Soluble B7-H4 and Circulating Tumor Cells in Blood of Advanced Epithelial Ovarian Cancer PatientsIn: Frontiers in Oncology , Jg. 11 2021, 721067DOI, Online Volltext (Open Access)
-
Cancer field surgery in endometrial cancer : Peritoneal mesometrial resection and targeted compartmental lymphadenectomy for locoregional controlIn: Journal of Gynecologic Oncology , Jg. 32 2021, Nr. 1, S. e7DOI (Open Access)
-
Circulating Maternal sFLT1 (Soluble fms-Like Tyrosine Kinase-1) Is Sufficient to Impair Spiral Arterial Remodeling in a Preeclampsia Mouse ModelIn: Hypertension , Jg. 78 2021, Nr. 4, S. 1067 – 1079DOI (Open Access)
-
Development and Validation of an Objective Scoring Tool to Evaluate Surgical Dissection : Dissection Assessment for Robotic Technique (DART)In: Urology Practice , Jg. 8 2021, Nr. 5, S. 596 – 604DOI (Open Access)
-
Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancerIn: International Journal of Gynecological Cancer , Jg. 31 2021, Nr. 5, S. 647 – 655DOI (Open Access)
-
Evaluation of carcinoembryonic antigen-related cell adhesion molecule 1 blood serum levels in women at high risk for preeclampsiaIn: American Journal of Reproductive Immunology , Jg. 85 2021, Nr. 5, e13375
-
HDAC Inhibition Induces Cell Cycle Arrest and Mesenchymal-Epithelial Transition in a Novel Pleural-Effusion Derived Uterine Carcinosarcoma Cell LineIn: Pathology & Oncology Research , Jg. 27 2021, 636088DOI, Online Volltext (Open Access)
-
HER2 Receptor Conversion Is a strong Survival Predictor in Patients with Breast Cancer Brain MetastasesIn: World Neurosurgery , Jg. 152 2021, S. e332 – e343
-
Image-based identification and genomic analysis of single circulating tumor cells in high grade serous ovarian cancer patientsIn: Cancers , Jg. 13 2021, Nr. 15, 3748DOI, Online Volltext (Open Access)
-
Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancerIn: Genome Medicine , Jg. 13 2021, Nr. 1, 85DOI, Online Volltext (Open Access)
-
Krebsfeldchirurgie des Endometriumkarzinoms : Erste Ergebnisse zur lokoregionären Kontrolle durch PMMR und „targeted compartmental lymphadenectomy“In: Der Gynäkologe , Jg. 54 2021, S. 840 – 845
-
Left Ventricular Diastolic Function Following Anthracycline-Based Chemotherapy in Patients with Breast Cancer without Previous Cardiac Disease : A Meta-AnalysisIn: Journal of Clinical Medicine (JCM) , Jg. 10 2021, Nr. 17, 3890DOI (Open Access)
-
Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer PatientsIn: Cells , Jg. 10 2021, Nr. 2, S. 212DOI (Open Access)
-
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancerIn: Journal of Cancer Research and Clinical Oncology , Jg. 147 2021, Nr. 8, S. 2233 – 2238DOI (Open Access)
-
Successful myometrial closure over protruding Cesarean scar pregnancyIn: Ultrasound in Obstetrics and Gynecology , Jg. 57 2021, Nr. 6, S. 1010 – 1011DOI (Open Access)
-
Uterine Artery Embolization in the Twentieth Week of Pregnancy in Abnormally Invasive Placenta with Live BirthIn: Journal of Vascular and Interventional Radiology (JVIR) , Jg. 32 2021, Nr. 3, S. 339 – 342
-
Zinc distribution within breast cancer tissue of different intrinsic subtypesIn: Archives of Gynecology and Obstetrics , Jg. 303 2021, S. 195 – 205DOI (Open Access)
-
CCN3 Signaling Is Differently Regulated in Placental Diseases Preeclampsia and Abnormally Invasive PlacentaIn: Frontiers in Endocrinology , Jg. 11 2020, 597549DOI, Online Volltext (Open Access)
-
CXCR4 and JUNB double-positive disseminated tumor cells are detected frequently in breast cancer patients at primary diagnosisIn: Therapeutic Advances in Medical Oncology , Jg. 12 2020DOI (Open Access)
-
Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast CancerIn: Frontiers in Oncology , Jg. 10 2020, S. 1658DOI, Online Volltext (Open Access)
-
Circulating tumor cells expressing the prostate specific membrane antigen PSMA indicate worse outcome in triple-negative breast cancer patients at primary diagnosisIn: Cancer Research , Jg. 80 2020, Nr. 4
-
Definition and independent validation of a proteomic-classifier in ovarian cancerIn: Cancers , Jg. 12 2020, Nr. 9, S. 2519DOI (Open Access)
-
Dilution of molecular–pathologic gene signatures by medically associated factors might prevent prediction of resection status after debulking surgery in patients with advanced ovarian cancerIn: Clinical Cancer Research , Jg. 26 2020, Nr. 1, S. 213 – 219DOI (Open Access)
-
Erfolgreiche Embolisation zervikaler Äste der Uterinarterien in 17. Schwangerschaftswoche bei blutender AIP (abnormally invasive placenta) mit LebendgeburtIn: Geburtshilfe und Frauenheilkunde , Jg. 80 2020, Nr. 10, S. E274 – E275
-
Fetal subdural hematoma, sickle cell disease and storage pool disease : A case reportIn: Case Reports in Women's Health , Jg. 26 2020, e00183DOI, Online Volltext (Open Access)
-
High serum levels of periostin are associated with a poor survival in breast cancerIn: Breast Cancer Research and Treatment , Jg. 180 2020, Nr. 2, S. 515 – 524
-
IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology : Beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancersIn: International Journal of Gynecological Cancer , Jg. 30 2020, Nr. 5, S. 670 – 683DOI (Open Access)
-
Liquid Biopsies to Evaluate Immunogenicity of Gynecological/Breast Tumors : On the Way to Blood-Based Biomarkers for ImmunotherapiesIn: Breast Care , Jg. 15 2020, Nr. 5, S. 470 – 480DOI (Open Access)
-
MR-proANP, a cardiovascular biomarker to predict late-onset preeclampsia and intrauterine growth restricted fetusesIn: Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health , Jg. 22 2020, S. 54 – 58
-
Minimal-invasive Operationen beim EndometriumkarzinomIn: Der Gynäkologe , Jg. 53 2020, Nr. 8, S. 547 – 551
-
Minimalinvasive Chirurgie des Zervixkarzinoms : Konsequenzen aus der LACC-StudieIn: Der Urologe , Jg. 59 2020, Nr. 3, S. 344 – 346
-
Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple-negative breast cancer patientsIn: Journal of Cellular and Molecular Medicine , Jg. 24 2020, Nr. 15, S. 8405 – 8416DOI, Online Volltext (Open Access)
-
Multimodal targeted deep sequencing of circulating tumor cells and matched cell-free DNA provides a more comprehensive tool to identify therapeutic targets in metastatic breast cancer patientsIn: Cancers , Jg. 12 2020, Nr. 5DOI, Online Volltext (Open Access)
-
Robot assisted surgery during the COVID-19 pandemic, especially for gynecological cancer: A statement of the society of european robotic gynaecological surgery (SERGS)In: Journal of Gynecologic Oncology , Jg. 31 2020, Nr. 3, S. e59DOI (Open Access)
-
Robotics – „smart medicine“ in der minimal-invasiven gynäkologischen ChirurgieIn: Der Gynäkologe , Jg. 53 2020, Nr. 9, S. 607 – 613
-
Sentineltechnik mit ICG in der Gynäkologie : Literaturübersicht und eigene ErfahrungenIn: Der Gynäkologe , Jg. 53 2020, Nr. 7, S. 463 – 466
-
Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patientsIn: Cellular and Molecular Life Sciences - CMLS , Jg. 77 2020, Nr. 3, S. 497 – 509DOI (Open Access)
-
The combined blood analysis of cell-free DNA and genomic DNA of circulating tumor cells reveals additive value in hormone receptor-positive, HER2-negative metastatic breast cancer patientsIn: Cancer Research , Jg. 80 2020, Nr. 4
-
The role of sentinel-node biopsy in ovarian cancerIn: Minerva Ginecologica , Jg. 72 2020, Nr. 6, S. 399 – 403
-
A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasmsIn: The New England Journal of Medicine , Jg. 380 2019, Nr. 9, S. 822 – 832DOI (Open Access)
-
Afamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionallyIn: Endocrine Connections , Jg. 8 2019, Nr. 5, S. 616 – 624DOI, Online Volltext (Open Access)
-
Aktuelle Möglichkeiten und Evidenz roboterassistierter Eingriffe in der chirurgischen OnkologieIn: Der Onkologe 2019
-
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast CancerIn: Cancers , Jg. 11 2019, Nr. 2, S. 238DOI, Online Volltext (Open Access)
-
Deleterious somatic variants in 473 consecutive individuals with ovarian cancer : Results of the observational AGO-TR1 study (NCT02222883)In: Journal of Medical Genetics (eJMG) , Jg. 56 2019, Nr. 9, S. 574 – 580DOI, Online Volltext (Open Access)
-
Digital immune-related gene expression signatures in high-grade serous ovarian carcinoma : Developing prediction models for platinum responseIn: Cancer Management and Research , Jg. 11 2019, S. 9571 – 9583DOI, Online Volltext (Open Access)
-
Dilution of molecular-pathologic gene signatures (MPG) by parameter unrelated to tumor biology (UTB) may prevent prediction of the resection status after debulking surgery in patients with advanced ovarian cancer : Oral Communication 3 – Ovarian CancerIn: International Journal of Gynecological Cancer , Jg. 29 2019, Nr. Suppl. 4 , A 30
-
Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancerIn: BMC Cancer , Jg. 19 2019, Nr. 1, S. 120DOI (Open Access)
-
EGFR-Specific Tyrosine Kinase Inhibitor Modifies NK Cell-Mediated Antitumoral Activity against Ovarian Cancer CellsIn: International Journal of Molecular Sciences (IJMS) , Jg. 20 2019, Nr. 19DOI (Open Access)
-
Extracellular vesicle-associated miRNAs in ovarian cancer - design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistanceIn: Clinical Chemistry and Laboratory Medicine , Jg. 57 2019, Nr. 7, S. 1053 – 1062
-
HLA-G 3′ untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancerIn: Scientific Reports , Jg. 9 2019, Nr. 1, S. 5407DOI, Online Volltext (Open Access)
-
High circulating levels of Periostin are associated with a poor survival in primary, non-metastatic breast cancer patientsIn: Cancer Research , Jg. 79 2019, Nr. Suppl. 4
-
Human sFLT1 leads to severe changes in placental differentiation and vascularization in a transgenic hsFLT1/rtTA FGR mouse modelIn: Frontiers in Endocrinology , Jg. 10 2019, 165DOI, Online Volltext (Open Access)
-
In primary, non-metastatic breast cancer patients, increased serum levels of RANKL significantly correlate with tumor cell spread to the bone and the occurrence of bone metastasis whereas high levels of its soluble decoy receptor osteoprotegerin predict poor survivalIn: Cancer Research , Jg. 79 2019, Nr. Suppl. 4
-
Kompartmentbasierte Chirurgie und Sentinel-Konzept beim Endometriumkarzinom: der Essener Weg : Vorschlag für eine rationale, risikoadaptierte chirurgische TherapieIn: Der Gynäkologe , Jg. 52 2019, Nr. 7, S. 538 – 541
-
Prognostic significance of PD-1 and PD-L1 positive tumor-infiltrating immune cells in ovarian carcinomaIn: International Journal of Gynecological Cancer , Jg. 29 2019, Nr. 9, S. 1389 – 1395
-
Prognostic value of RANKL/OPG serum levels and disseminated tumor cells in nonmetastatic breast cancerIn: Clinical Cancer Research , Jg. 25 2019, Nr. 4, S. 1369 – 1378DOI (Open Access)
-
Robot-assisted approach to cervical cancer (RACC) : An international multi-center, open-label randomized controlled trialIn: International Journal of Gynecological Cancer , Jg. 29 2019, Nr. 6, S. 1072 – 1076DOI, Online Volltext (Open Access)
-
Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian CancerIn: Frontiers in Oncology , Jg. 9 2019DOI (Open Access)
-
Surgical resection based on ontogenetic cancer field theory for cervical cancer : mature results from a single-centre, prospective, observational, cohort studyIn: The Lancet Oncology , Jg. 20 2019, Nr. 9, S. 1316 – 1326
-
The analysis of cell-free DNA and circulating tumor cells from one blood tube might empower treatment decisions in metastatic breast cancer patientsIn: Cancer Research , Jg. 79 2019, Nr. Suppl. 4
-
Trends in axillary lymph node dissection for early-stage breast cancer in Europe : Impact of evidence on practiceIn: The Breast , Jg. 45 2019, S. 89 – 96DOI (Open Access)
-
Updated Opinion of the Uterus Commission of the Gynecological Oncology Working Group (AGO) and the Gynecological Endoscopy Working Group (AGE) of the German Society of Gynecology and Obstetrics (DGGG) on the Randomized Study Comparing Minimally Invasive with Abdominal Radical Hysterectomy for Early-stage Cervical Cancer (LACC)In: Geburtshilfe und Frauenheilkunde , Jg. 79 2019, Nr. 2, S. 145 – 147DOI (Open Access)
-
Vesicular-Bound HLA-G as a Predictive Marker for Disease Progression in Epithelial Ovarian CancerIn: Cancers , Jg. 11 2019, Nr. 8, S. 1106DOI (Open Access)
-
Was Morbus Osler und Präeklampsie (nicht) gemeinsam habenIn: Der Gynäkologe , Jg. 52 2019, Nr. 1, S. 52 – 58
-
What is the evidence for lymphadenectomy in presumed early ovarian cancer?In: Archives of Gynecology and Obstetrics , Jg. 299 2019, Nr. 1, S. 1 – 5
-
Afamin : an early predictor of preeclampsiaIn: Archives of Gynecology and Obstetrics , Jg. 298 2018, Nr. 5, S. 1009 – 1016DOI (Open Access)
-
Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapyIn: OncoImmunology , Jg. 7 2018, Nr. 1, e1376153DOI (Open Access)
-
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) – Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare FacilitiesIn: Geburtshilfe und Frauenheilkunde , Jg. 78 2018, Nr. 11, S. 1089 – 1109DOI (Open Access)
-
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer.In: Geburtshilfe und Frauenheilkunde , Jg. 78 2018, Nr. 10, S. 949 – 971DOI (Open Access)
-
Is Afamin a novel biomarker for gestational diabetes mellitus? : A pilot studyIn: Reproductive Biology and Endocrinology , Jg. 16 2018, 30DOI (Open Access)
-
Minimally invasive surgery for cervical cancer : consequences for treatment after LACC StudyIn: Journal of Gynecologic Oncology , Jg. 29 2018, Nr. 4, S. e75DOI (Open Access)
-
Operative Therapie des EndometriumkarzinomsIn: Der Gynäkologe , Jg. 51 2018, Nr. 12, S. 1024 – 1031
-
Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancyIn: Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health , Jg. 12 2018, S. 124 – 128
-
RNA profiles of circulating tumor cells and extracellular vesicles for therapy stratification of metastatic breast cancer patientsIn: Clinical Chemistry , Jg. 64 2018, Nr. 7, S. 1054 – 1062
-
Simultaneous multiparametric PET/MRI for the assessment of therapeutic response to chemotherapy or concurrent chemoradiotherapy of cervical cancer patients : preliminary resultsIn: Clinical Imaging , Jg. 49 2018, S. 163 – 168
-
Soluble B7-H4 blood serum levels are elevated in women at high risk for preeclampsia in the first trimester, as well as in patients with confirmed preeclampsiaIn: American Journal of Reproductive Immunology , Jg. 80 2018, Nr. 3, S. e12988
-
The Society of European Robotic Gynaecological Surgery (SERGS) Pilot Curriculum for robot assisted gynecological surgeryIn: Archives of Gynecology and Obstetrics , Jg. 297 2018, Nr. 2, S. 415 – 420DOI (Open Access)
-
The association of soluble HLA-G levels and 3 untranslated region haplotypes of the HLA-G gene with the clinical profile of epithelial ovarian cancer patients regarding disease stage, circulating tumor cells and overall survivalIn: HLA: Immune Response Genetics (Human Leukocyte Antigens) , Jg. 91 2018, Nr. 5, S. 467 – 467
-
Tight interplay in early pregnancy between follistatin and anti-mullerian hormone in women with polycystic ovarian syndrome (PCOS)In: Archives of Gynecology and Obstetrics , Jg. 297 2018, Nr. 5, S. 1307 – 1316
-
Trends in anti-Müllerian hormone concentrations across different stages of pregnancy in women with polycystic ovary syndromeIn: Reproductive BioMedicine online (RBM) , Jg. 37 2018, Nr. 3, S. 367 – 374
-
Aortic utero-ovarian sentinel nodes and left infrarenal aortic lymph node dissection by ICG supported navigationIn: Gynecologic Oncology Reports , Jg. 20 2017, S. 22 – 23DOI (Open Access)
-
Circulating tumor cells in triple-negative breast cancer patients express prostate related genes and show different genetic profiles in US and German patient cohortsIn: Cancer Research , Jg. 77 2017, Nr. 4
-
Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patientsIn: Cancer Research , Jg. 77 2017, Nr. 4, S. P1 – 01
-
Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancerIn: Molecular Medicine Reports , Jg. 15 2017, Nr. 5, S. 2957 – 2968DOI (Open Access)
-
EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapyIn: OncoTarget , Jg. 8 2017, Nr. 30, S. 48820 – 48831DOI (Open Access)
-
ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancerIn: OncoTarget , Jg. 8 2017, Nr. 15, S. 24303 – 24313DOI (Open Access)
-
Early ovarian cancer surgery with indocyanine-green-guided targeted compartmental lymphadenectomy (TCL, pelvic part)In: Journal of Gynecologic Oncology , Jg. 28 2017, Nr. 5, e68DOI (Open Access)
-
Follistatin during pregnancy and its potential role as an ovarian suppressing agentIn: European Journal of Obstetrics & Gynecology and Reproductive Biology , Jg. 212 2017, S. 150 – 154
-
Gene expression signatures in circulating tumor cells correlate with response to therapy in metastatic breast cancerIn: Clinical Chemistry , Jg. 63 2017, Nr. 10, S. 1585 – 1593
-
Impact of maternal serum levels of Visfatin, AFP, PAPP-A, sFlt-1 and PlGF at 11–13 weeks gestation on small for gestational age birthsIn: The Journal of Maternal-Fetal & Neonatal Medicine , Jg. 30 2017, Nr. 6, S. 629 – 634
-
LION : Lymphadenectomy in ovarian neoplasms-A prospective randomized AGO study group led gynecologic cancer intergroup trialIn: Journal of Clinical Oncology (JCO) , Jg. 35 2017, Nr. 15 Suppl., S. 5500
-
Lion - Lymphadenectomy in Ovarian Neoplasms. A Prospective Randomized AGO Study Group LED Gynecologic Cancer Intergroup TrialIn: International Journal of Gynecological Cancer , Jg. 27 2017, Nr. Suppl. 4 , S. 9 Abstract ESGO7-084
-
Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).In: PLoS ONE , Jg. 12 2017, Nr. 10, S. e0186043DOI (Open Access)
-
Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology TraineesIn: International Journal of Gynecological Cancer , Jg. 27 2017, Nr. 2, S. 375 – 381DOI (Open Access)
-
Serum levels of RANKL are increased in primary breast cancer patients in the presence of disseminated tumor cells in the bone marrowIn: Cancer Research , Jg. 77 2017, Nr. 4
-
Soluble CEACAM1 and CEACAM6 are differently expressed in blood serum of pregnant women during normal pregnancyIn: American Journal of Reproductive Immunology , Jg. 78 2017, Nr. 4, S. e12700
-
Spätfolgen der Sectioentbindung: Narbendefekte und Plazentationsstörungen : Vorbeugen, erkennen, behandelnIn: Der Gynäkologe , Jg. 50 2017, Nr. 10, S. 785 – 792
-
Surgical anatomy of the ligamentous mesometrium and robotically assisted ICG-guided resection in cervical cancerIn: Gynecologic Oncology Reports , Jg. 20 2017, S. 4DOI (Open Access)
-
Surgical treatment of early ovarian cancer with compartmental resection of regional lymphatic network and indocyanine-green-guided targeted compartmental lymphadenectomy (TCL, paraaortic part)In: Journal of Gynecologic Oncology , Jg. 28 2017, Nr. 3, S. e41DOI (Open Access)
-
Technique of ICG-guided Targeted Compartmental Pelvic Lymphadenectomy (TCL) combined with Pelvic Peritoneal Mesometrial Resection (PMMR) for locoregional control of endometrial cancer – A proposalIn: Gynecologic Oncology Reports , Jg. 20 2017, S. 125 – 126DOI (Open Access)
-
Time trends (2006–2015) of quality indicators in EUSOMA-certified breast centresIn: European Journal of Cancer (EJC) , Jg. 85 2017, S. 15 – 22
-
Afamin – ein früher Marker für das Auftreten einer PräeklampsieIn: Geburtshilfe und Frauenheilkunde , Jg. 76 2016, Nr. 5, S. BoB2
-
Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer : Do stem cell like cells predict prognosis?In: OncoTarget , Jg. 7 2016, Nr. 18, S. 26454 – 26464DOI (Open Access)
-
B3-lesions of the breast and cancer risk - an analysis of mammography screening patientsIn: Molecular and Clinical Oncology , Jg. 4 2016, Nr. 5, S. 705 – 708
-
Breast cancer-derived extracellular vesicles : clinical and prognostic impactIn: Cancer Research , Jg. 76 2016, Nr. 14 Suppl., S. 3152
-
Caspase-8 Polymorphisms As Independent Prongostic Factors For Survival In Breast Cancer PatientsIn: International Journal of Gynecological Cancer , Jg. 26 2016, Nr. Suppl. 2, S. 30
-
Circulating tumor cells in triple-negative and non-triple negative breast cancer patients show different genetic profilesIn: Cancer Research , Jg. 76 2016, Nr. 4 Suppl. , P2-02-05
-
Different prognostic value of circulating and disseminated tumor cells in primary breast cancer : Influence of bisphosphonate intake?In: Scientific Reports , Jg. 6 2016, S. 26355DOI (Open Access)
-
Distant metastasis detected by routine staging in breast cancer patients participating in the national German screening programme : consequences for clinical practiceIn: SpringerPlus , Jg. 5 2016, Nr. 1, S. 1010DOI (Open Access)
-
Do disseminated tumor cells with stem cell character after therapy predict prognosis in primary ovarian cancerIn: Cancer Research , Jg. 76 2016, Nr. 14 Suppl., S. 2492
-
Does primary neoadjuvant systemic therapy eradicate minimal residual disease? : Analysis of disseminated and circulating tumor cells before and after therapyIn: Breast Cancer Research , Jg. 18 2016, 20DOI (Open Access)
-
Embryologically based radical hysterectomy as peritoneal mesometrial resection (PMMR) with pelvic and para-aortic lymphadenectomy for loco-regional tumor control in endometrial cancer : first evidence for efficacyIn: Archives of Gynecology and Obstetrics , Jg. 294 2016, Nr. 1, S. 153 – 160DOI (Open Access)
-
Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatmentIn: OncoTarget , Jg. 7 2016, Nr. 27, S. 41677 – 41690DOI (Open Access)
-
Evaluation of a novel ELISA for the tumor-associated antigen CA 72-4 in patients with ovarian cancerIn: International Journal of Pharmacokinetics , Jg. 2 2016, Nr. 4, S. FSO145DOI (Open Access)
-
Gene expression signatures in circulating tumor cells are prognostic for metastatic lesions in breast cancer patients and correlate with response to therapyIn: Cancer Research , Jg. 76 2016, Nr. 14 Suppl., S. 502
-
ICG-gestützte Navigation bei der Chirurgie uteriner MalignomeIn: Der Gynäkologe , Jg. 49 2016, Nr. 5, S. 373 – 380
-
Implementation of Enhanced Recovery After Surgery (ERAS) Pathways in Gynecologic Oncology : A NOGGO-AGO* survey of 144 Gynecological Departments in GermanyIn: Anticancer Research , Jg. 36 2016, Nr. 8, S. 4227 – 4232
-
In primary breast cancer patients with HER2-negative tumors, HER2-positive circulating tumor cells with stem cell character predict worse outcomeIn: Cancer Research , Jg. 76 2016, Nr. 4 Suppl. , P2-02-01
-
Intraoperative navigation in robotically assisted compartmental surgery of uterine cancer by visualisation of embryologically derived lymphatic networks with indocyanine-green (ICG)In: Journal of Surgical Oncology , Jg. 113 2016, Nr. 5, S. 554 – 559DOI (Open Access)
-
Kongressbericht – Roboterchirurgie-KongressIn: Geburtshilfe und Frauenheilkunde , Jg. 76 2016, Nr. 9, S. 933 – 933
-
Left paraaortic, inframesenteric lymphadenectomy preserving the superior hypogastric plexus supported by indocyanine green (ICG) labeling of the lymphatic compartment in cervical cancerIn: Gynecologic Oncology Reports , Jg. 18 2016, S. 14DOI (Open Access)
-
Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer : a multicentric analysis of rates of pathologic complete response and survivalIn: Chemotherapy , Jg. 28 2016, Nr. 3, S. 210 – 217DOI (Open Access)
-
Oncological outcomes of robotic-assisted radical hysterectomyIn: Minerva Ginecologica , Jg. 68 2016, Nr. 1, S. 43 – 48
-
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)In: International Journal of Gynecological Cancer , Jg. 26 2016, Nr. 9, S. 1636 – 1641
-
Plasmapherese bei einem lebensbedrohlichen Fall von HELLP-Syndrom in der 18. SchwangerschaftswocheIn: Geburtshilfe und Frauenheilkunde , Jg. 76 2016, Nr. 5, S. P01
-
Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancerIn: BMC Cancer , Jg. 16 2016, S. 618DOI (Open Access)
-
Prognostische Relevanz von Caspase-8 Polymorphismen für das MammakarzinomIn: Geburtshilfe und Frauenheilkunde , Jg. 76 2016, Nr. 5 , A 30
-
Risk-reducing, conservative mastectomy-analysis of surgical outcome and quality of life in 272 implant-based reconstructions using TiLoop(®) Bra versus autologous corial flapsIn: Gland Surgery , Jg. 5 2016, Nr. 1, S. 1 – 8
-
Roboterchirurgie in der Gynäkologie – Status quoIn: Der Gynäkologe , Jg. 49 2016, Nr. 6, S. 470 – 476
-
Robotically assisted peritoneal mesometrial resection (PMMR) in endometrial cancer supported by ICG labeling of the compartmental lymphatic systemIn: Gynecologic Oncology Reports , Jg. 16 2016, S. 24DOI (Open Access)
-
Serum concentrations of soluble B7-H4 in early pregnancy are elevated in women with preterm premature rupture of fetal membranesIn: American Journal of Reproductive Immunology , Jg. 76 2016, Nr. 2, S. 149 – 154
-
The Use of Plasma Exchange in a Very Early-onset and Life Threatening, Hemolysis, Elevated Liver Enzymes, and Low Platelet (HELLP) Syndrome : A Case ReportIn: Gynecology & Obstetrics , Jg. 6 2016, Nr. 6, S. 387DOI (Open Access)
-
The co-stimulatory soluble B7-H4 molecule is elevated in early pregnancy in women with premature rupture of fetal membranesIn: Journal of Reproductive Immunology , Jg. 115 2016, S. 67
-
The presence and persistence of ERCC1 positive circulating tumor cells predicts worse prognosis in primary ovarian cancer patientsIn: Cancer Research , Jg. 76 2016, Nr. 14 Suppl., S. 447
-
The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patientsIn: Human Immunology , Jg. 77 2016, Nr. 9, S. 791 – 799
-
Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II AssayIn: Reproductive Biology and Endocrinology , Jg. 13 2015, Nr. 1, 86DOI (Open Access)
-
Association between tumor infiltrating immune cells, circulating tumor cells in blood and disseminated tumor cells in the bone marrow in patients with primary ovarian cancerIn: Cancer Research , Jg. 75 2015, Nr. 15 Suppl.
-
Bedeutung der Insulinresistenz beim polyzystischen Ovarsyndrom – prä- und postkonzeptionellIn: Der Gynäkologe , Jg. 48 2015, Nr. 12, S. 903 – 908
-
Breast conservative surgery and local recurrenceIn: The Breast , Jg. 24 2015, Nr. Suppl. 1, S. S18 – S19
-
Breast conservative surgery and local recurrenceIn: The Breast , Jg. 24 2015, Nr. Suppl. 2, S. 100 – S107
-
CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplantsIn: British Journal of Haematology , Jg. 169 2015, Nr. 6, S. 868 – 878
-
Change of anti-Mullerian-hormone levels during follicular phase in PCOS patientsIn: Gynecological Endocrinology , Jg. 31 2015, Nr. 1, S. 26 – 30
-
Changes in the Blood Serum Levels of the Costimulatory Soluble B7-H4 Molecule in Pregnant Women During the Peripartal PhaseIn: American Journal of Reproductive Immunology , Jg. 74 2015, Nr. 3, S. 209 – 215
-
Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancerIn: Journal of Cancer Research and Clinical Oncology , Jg. 141 2015, Nr. 1, S. 87 – 92
-
Different prognostic value of circulating and disseminated tumor cells in primary breast cancer : Influence of bisphosphonate intake?In: Cancer Research , Jg. 75 2015, Nr. 9 Suppl.
-
ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum-restistanceIn: International Journal of Gynecological Cancer , Jg. 25 2015, Nr. 9 (Supplement 1), S. 464
-
Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-upIn: Archives of Gynecology and Obstetrics , Jg. 292 2015, Nr. 5, S. 1117 – 1125
-
Expression profiling of circulating tumor cells : A prognostic and predictive biomarker in metastatic breast cancerIn: Cancer Research , Jg. 75 2015, Nr. 15 Suppl.
-
Follow-up in Gynecological Malignancies : A State of ArtIn: International Journal of Gynecological Cancer , Jg. 25 2015, Nr. 7, S. 1151 – 1164
-
Impact of Age, Obesity and Smoking on Patient Satisfaction with Breast Implant Surgery – A Unicentric Analysis of 318 Implant Reconstructions after MastectomyIn: Geburtshilfe und Frauenheilkunde , Jg. 75 2015, Nr. 6, S. 597 – 604DOI (Open Access)
-
Influence of lifestyle factors and tumor cell dissemination in 632 early breast cancer patientsIn: Cancer Research , Jg. 75 2015, Nr. 9 Suppl.
-
Maternal serum copeptin, MR-proANP and procalcitonin levels at 11–13 weeks gestation in the prediction of preeclampsiaIn: Archives of Gynecology and Obstetrics , Jg. 292 2015, Nr. 5, S. 1033 – 1042
-
Molecular characterization of circulating tumor cells allows stratifying for prognosis in breast cancer patients undergoing neoadjuvant therapyIn: Cancer Research , Jg. 75 2015, Nr. 15 Suppl.
-
Oxygen Sensitivity of Placental Trophoblast Connexins 43 and 46 : A Role in Preeclampsia?In: Journal of Cellular Biochemistry , Jg. 116 2015, Nr. 12, S. 2924 – 2937
-
Prognostic impact of residual disease after neoadjuvant chemotherapy in 648 patients with triple-negative breast cancerIn: Anticancer Research , Jg. 35 2015, Nr. 10, S. 5479 – 5484
-
Single nucleotide polymorphisms of the EpCAM-coding gene TACSTD1 in patients with ovarian cancer and their potential translational aspectsIn: Archives of Gynecology and Obstetrics , Jg. 292 2015, Nr. 6, S. 1367 – 1372
-
Stage-related risk categorization and influence of free margins on survival in triple negative early breast cancer - a population-based study of 2037 TNBC patients with adjuvant chemotherapyIn: Cancer Research , Jg. 75 2015, Nr. Suppl. 9 , P2-13-01
-
Substanzabusus in der Schwangerschaft : Auswirkungen auf die Schwangere und den FetenIn: Der Gynäkologe , Jg. 48 2015, Nr. 6, S. 464 – 469
-
Systematization of Oncoplastic Surgery : Selection of Surgical Techniques and Patient-Reported Outcome in a Cohort of 1,035 PatientsIn: Annals of Surgical Oncology , Jg. 22 2015, Nr. 11, S. 3730 – 3737DOI (Open Access)
-
The AdnaCellector, a new fully automated selection for circulating tumor cells in blood of primary and metastatic breast cancer patientsIn: Cancer Research , Jg. 75 2015, Nr. 15 Suppl.
-
The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patientsIn: British Journal of Clinical Pharmacology (BJCP) , Jg. 80 2015, Nr. 5, S. 1139 – 1148DOI (Open Access)
-
The effect of EUSOMA certification on quality of breast cancer careIn: European Journal of Surgical Oncology , Jg. 41 2015, Nr. 10, S. 1423 – 1429
-
The prognostic impact of soluble HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patientsIn: Tissue Antigens , Jg. 86 2015, Nr. 2, S. 81
-
The value of serum CA125 in the diagnosis of borderline tumors of the ovary : A subanalysis of the prospective multicenter ROBOT studyIn: International Journal of Gynecological Cancer , Jg. 25 2015, Nr. 7, S. 1248 – 1252DOI (Open Access)
-
Translating the concept of intrinsic subtypes into an oncoplastic cohort of more than 1000 patients - predictors of recurrence and survivalIn: The Breast , Jg. 24 2015, Nr. 4, S. 384 – 390DOI (Open Access)
-
Translating the concept of intrinsic subtypes into an oncoplastic cohort of more than 1000 patients-predictors of recurrence and survivalIn: Cancer Research , Jg. 75 2015, Nr. 9 Suppl.
-
A fully automated q-PCR-based circulating tumor cell analysis using the Alere TM q-Analyzer test platformIn: Cancer Research , Jg. 74 2014, Nr. Suppl. 19, S. 3076
-
Additional B-cell deficiency does not affect growth and angiogenesis of ectopic human endometrium in T-cell-deficient endometriosis mouse models during long-term cultureIn: Journal of Reproductive Immunology , Jg. 106 2014, Nr. 1, S. 50 – 57
-
Anti-Mullerian Hormone : an indicator for the severity of polycystic ovarian syndromeIn: Archives of Gynecology and Obstetrics , Jg. 290 2014, Nr. 5, S. 1023 – 1030
-
Circulating U2 Small Nuclear RNA Fragments as a Novel Diagnostic Tool for Patients with Epithelial Ovarian CancerIn: Clinical Chemistry , Jg. 60 2014, Nr. 1, S. 206 – 213
-
Detection of disseminated tumor cells in the bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancerIn: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15 Suppl., S. e22032
-
ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum ResistanceIn: Clinical Chemistry , Jg. 60 2014, Nr. 10, S. 1282 – 1289
-
Establishment of a new method for the selection and detection of circulating tumor cells in metastatic breast cancer patientsIn: Cancer Research , Jg. 74 2014, Nr. 19 Suppl.
-
Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevanceIn: Gynecologic Oncology , Jg. 133 2014, Nr. 3, S. 467 – 472
-
Incorporation of pazopanib in maintenance therapy of ovarian cancerIn: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 30, S. 3374 – 3381
-
Innovationen in der operativen Therapie von GenitalkarzinomenIn: Der Gynäkologe , Jg. 47 2014, Nr. 12, S. 967 – 973
-
Intraindividual right-left comparison of sonographic features in polycystic ovary syndrome (PCOS) diagnosisIn: European Journal of Obstetrics & Gynecology and Reproductive Biology , Jg. 181 2014, S. 124 – 129
-
Laparoscopy and robot-assisted surgery in gynecologyIn: Der Gynäkologe , Jg. 47 2014, Nr. 3, S. 164DOI (Open Access)
-
Laudatio. Univ.-Prof. Dr. med. Hermann Hepp feiert seinen 80. GeburtstagIn: Geburtshilfe und Frauenheilkunde , Jg. 74 2014, Nr. 3, S. 217 – 218
-
Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer : A multicentric analysis of feasibility and rates of pathologic complete responseIn: Chemotherapy , Jg. 59 2014, Nr. 5, S. 387 – 394DOI (Open Access)
-
Predictive markers for the FSH sensitivity of women with polycystic ovarian syndromeIn: Human Reproduction , Jg. 29 2014, Nr. 3, S. 518 – 524
-
Serum concentrations of afamin are elevated in patients with polycystic ovary syndromeIn: Endocrine Connections , Jg. 3 2014, Nr. 3, S. 120 – 126DOI (Open Access)
-
Single nucleotide polymorphism of the EpCAM-coding gene TACSTD1 in patients with ovarian cancer and their potential implications in clinical practiceIn: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15 Suppl., S. e16515
-
Synchronous ovarian and endometrial cancer-an international multicenter case-control studyIn: International Journal of Gynecological Cancer , Jg. 24 2014, Nr. 1, S. 54 – 60
-
The FNTB-609G>C polymorphism as a possible predictive factor for efficacy of lonafarnib-treatment? : Exploratory analysis of a randomized phase II clinical trial in stage IIb-IV ovarian cancer, treated with first-line platinum-based chemotherapy with or without lonafarnibIn: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15 Suppl., S. e16534
-
The haplotype of three polymorphisms in the SATB1 promoter region impacts survival in breast cancer patientsIn: Oncology Letters , Jg. 7 2014, Nr. 6, S. 2007 – 2012DOI (Open Access)
-
„Robotic surgery“ in der Gynäkologie : Stand und AusblickIn: Der Gynäkologe , Jg. 47 2014, Nr. 3, S. 184 – 190
-
Addition of vandetanib to pegylated liposomal doxorubicin (PLD) in patients with recurrent ovarian cancer. A randomized phase I/II study of the AGO Study Group (AGO-OVAR 2.13)In: Investigational New Drugs: The Journal of New Anticancer Agents , Jg. 31 2013, Nr. 6, S. 1499 – 1504
-
Anti-Mullerian-hormone levels during pregnancy and postpartumIn: Reproductive Biology and Endocrinology , Jg. 11 2013, Nr. 1, 60
-
Clinical relevance of VEGF-receptor status in primary ovarian cancer : A pilot study for future biomarker analysesIn: Journal of Clinical Oncology (JCO) , Jg. 31 2013, Nr. 15, Suppl., S. 5556
-
Definition of compartment based radical surgery in uterine cancer-part I : therapeutic pelvic and periaortic lymphadenectomy by Michael höckel translated to robotic surgeryIn: ISRN Obstetrics and Gynecology 2013, S. 297921
-
Definition of compartment-based radical surgery in uterine cancer : Modified radical hysterectomy in intermediate/high-risk endometrial cancer using peritoneal mesometrial resection (PMMR) by M Höckel translated to robotic surgeryIn: World Journal of Surgical Oncology , Jg. 11 2013, S. 198DOI (Open Access)
-
Definition of compartment-based radical surgery in uterine cancer : radical hysterectomy in cervical cancer as 'total mesometrial resection (TMMR)' by M Höckel translated to robotic surgery (rTMMR)In: World Journal of Surgical Oncology , Jg. 11 2013, S. 211DOI (Open Access)
-
Endometriumkarzinom operative Strategie und adjuvanz : Ein möglicher ParadigmenwechselIn: Der Gynäkologe , Jg. 46 2013, Nr. 5, S. 339 – 344
-
Establishment of a multimarker gene panel for the characterization of circulating tumor cells in metastatic breast cancerIn: Cancer Research , Jg. 73 2013, Nr. 8 Suppl.
-
Evaluation and correlation of risk recurrence in early breast cancer assessed by Oncotype DX, clinicopathological markers and tumor cell dissemination in the blood and bone marrowIn: Molecular and Clinical Oncology , Jg. 1 2013, Nr. 6, S. 1049 – 1054
-
Evaluation of risk recurrence in early breast cancer assessed by Oncotype DX and tumor cell dissemination to blood and bone marrowIn: Journal of Clinical Oncology (JCO) , Jg. 31 2013, Nr. Suppl. 15, S. e11516
-
Glycogen-rich, clear cell breast cancer : An underestimated histopathological risk factor?In: Cancer Research , Jg. 73 2013 , P6-06-23
-
Peritoneale mesometriale Resektion (PMMR) als Kompartiment-basierte Operation : Technik beim "intermediate/high risk" EndometriumkarzinomIn: Der Gynäkologe , Jg. 46 2013, Nr. 10, S. 751 – 756
-
Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancerIn: International Journal of Gynecological Cancer , Jg. 23 2013, Nr. 5, S. 839 – 845
-
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsIn: Breast Cancer Research and Treatment , Jg. 142 2013, Nr. 1, S. 81 – 88
-
Serum mass spectrometry analysis in primary ovarian cancer (OC) treated with surgery and adjuvant chemotherapy (CT)In: Journal of Clinical Oncology (JCO) , Jg. 31 2013, Nr. Suppl. 15
-
The persistence of ERCC1-positive circulating tumor cells predicts worse prognosis in patients with primary ovarian cancerIn: Cancer Research , Jg. 73 2013, Nr. Suppl. 8
-
Updated results of neoadjuvant chemotherapy with carboplatin AUC 6 and docetaxel 75 mg/m2 in triple-negative breast cancer (TNBC)In: Journal of Clinical Oncology (JCO) , Jg. 31 2013, S. 149 – 149
-
Utility of mesothelin, L1CAM and afamin as biomarkers in primary ovarian cancerIn: Anticancer Research , Jg. 33 2013, Nr. 1, S. 329 – 336
-
Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancerIn: Oncology Reports , Jg. 30 2013, Nr. 1, S. 441 – 447
-
A randomized phase iii adjuvant study in high-risk cervical cancer : Simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R) ; a noggo-ago intergroup studyIn: Annals of Oncology , Jg. 23 2012, Nr. 9, S. 2259 – 2264
-
Anti-epidermal growth factor receptor (EGFR) antibodies overcome resistance of ovarian cancer cells to targeted therapy and natural cytotoxicityIn: International Journal of Molecular Sciences (IJMS) , Jg. 13 2012, Nr. 9, S. 12000 – 12016DOI, Online Volltext (Open Access)
-
Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patientsIn: Acta Radiologica , Jg. 53 2012, Nr. 10, S. 1092 – 1098
-
Decidualization in human ectopic endometrial lesions in vivo is induced by hCGIn: Human Reproduction , Jg. 27 2012, Nr. Suppl. 2, S. O – 203
-
Detection of disseminated tumor cells in bone marrow as an independent prognostic factor in primary ovarian cancer patientsIn: Journal of Clinical Oncology (JCO) , Jg. 30 2012, Nr. 15, Suppl.
-
Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patientsIn: Acta Radiologica , Jg. 53 2012, Nr. 5, S. 518 – 523
-
ESGO Statement on the Role of CA-125 Measurement in Follow-Up of Epithelial Ovarian CancerIn: International Journal of Gynecological Cancer , Jg. 22 2012, Nr. 1, S. 175
-
Early detection of maternal risk for preeclampsiaIn: ISRN Obstetrics and Gynecology 2012, S. 172808
-
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cellsIn: Breast Cancer Research , Jg. 14 2012, Nr. 1, R15DOI, Online Volltext (Open Access)
-
FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients : Initial resultsIn: Acta Radiologica , Jg. 53 2012, Nr. 6, S. 628 – 636
-
LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survivalIn: BMC Cancer , Jg. 12 2012, S. 325DOI, Online Volltext (Open Access)
-
Mastectomy trends for early-stage breast cancer : A reprt from the EUSOMA multi-institutional European databaseIn: European Journal of Cancer (EJC) , Jg. 13 2012, Nr. 48, S. 1947 – 1956
-
Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell linesIn: BMC Cancer , Jg. 12 2012, S. 451DOI, Online Volltext (Open Access)
-
Morbidity of inguinofemoral lymphadenectomy in vulval cancerIn: The Scientific World Journal 2012, S. 341253
-
Schlafende Tumorzellen : Widerstandskämpfer der gynäkologischen TumorerkrankungenIn: Unikate: Berichte aus Forschung und Lehre 2012, Nr. 42: Translationale Krebsforschung: Auf dem Weg zu neuen Therapien, S. 80 – 89DOI, Online Volltext (Open Access)
-
Transvaginal Ultrasound for Endometrial Carcinoma Screening – Current Evidence-based DataIn: Geburtshilfe und Frauenheilkunde , Jg. 72 2012, Nr. 12, S. 1088 – 1091DOI (Open Access)
-
VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer CenterIn: Onkologie , Jg. 35 2012, Nr. Suppl. 6, S. 204 – 204
-
βhCG and PAPP-A in First Trimester : Predictive Factors for Preeclampsia?In: Hypertension in Pregnancy , Jg. 31 2012, Nr. 2, S. 261 – 267
-
„Robotic surgery“ beim Zervixkarzinom : Endoskopische Totale Mesometriale Resektion und therapeutische LymphonodektomieIn: Der Gynäkologe , Jg. 45 2012, Nr. 9, S. 707 – 713
-
A Phase 3 Trial of Bevacizumab in Ovarian CancerIn: The New England Journal of Medicine , Jg. 365 2011, Nr. 26, S. 2484 – 2496
-
Circulating 20S proteasome in patients with non-metastasized breast cancerIn: Anticancer Research , Jg. 31 2011, Nr. 6, S. 2197 – 2201(Open Access)
-
Comparison of PIK3CA Hot Spot Mutations in the Primary Tumor or Metastases with PIK3CA Mutations or PIK3CA Over-Expression in Circulating Tumor Cells of Metastatic Breast Cancer Patients under Sequential Palliative TherapyIn: Cancer Research , Jg. 71 2011, Nr. Suppl. 24
-
Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer : A pilot studyIn: Anticancer Research , Jg. 31 2011, Nr. 10, S. 3623 – 3628
-
Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients—Data from LIBERATE trialIn: Maturitas: The European Menopause Journal , Jg. 70 2011, Nr. 4, S. 365 – 372
-
EpCAM-autoantibody levels in the course of disease of ovarian cancer patientsIn: Medical Oncology , Jg. 28 2011, Nr. 2, S. 626 – 630
-
Impact of CCN3 (NOV) glycosylation on migration/invasion properties and cell growth of the choriocarcinoma cell line Jeg3In: Human Reproduction , Jg. 26 2011, Nr. 10, S. 2850 – 2860
-
Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patientsIn: International Journal of Cancer , Jg. 128 2011, Nr. 11, S. 2572 – 2580DOI (Open Access)
-
Intraoperative Irradiation of the Tumor bed as a Boost in the Burst-sustaining Primary treatment of Breast cancer - Initial results and issues that arisesIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 99 – 100
-
Loss of heterozygosity proximal to the M6P/IGF2R locus is predictive for the presence of disseminated tumor cells in the bone marrow of ovarian cancer patients before and after chemotherapyIn: Genes, Chromosomes and Cancer , Jg. 50 2011, Nr. 8, S. 598 – 605
-
Molecular Profiling and Prognostic Relevance of Circulating Tumor Cells in the Blood of Ovarian Cancer Patients at Primary Diagnosis and After Platinum-Based ChemotherapyIn: International Journal of Gynecological Cancer , Jg. 21 2011, Nr. 5, S. 822 – 830
-
Neoadjuvant platin and bevacizumab in triple-negative breast cancerIn: Journal of Clinical Oncology (JCO) , Jg. 29 2011, Nr. 15_suppl, S. e11591
-
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse : a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-studyIn: Annals of Oncology , Jg. 22 2011, Nr. 11, S. 2417 – 2423
-
Pathologic response rate (pCR) and near-pathologic response rate (near-pCR) with docetaxel-carboplatin (TCarb) in early triple-negative breast cancerIn: Journal of Clinical Oncology (JCO) , Jg. 29 2011, S. 277
-
Prädiktoren psychischer Belastungen bei Brustkrebspatientinnen : Worauf sollten Ärzte und Pflegekräfte in der onkologischen Praxis achten?In: Geburtshilfe und Frauenheilkunde , Jg. 71 2011, Nr. 4, S. 285 – 291
-
Randomized Phase III Trial of Sequential Adjuvant Chemoradiotherapy With or Without Erythropoietin Alfa in Patients With High-Risk Cervical Cancer : Results of the NOGGO-AGO Intergroup StudyIn: Journal of Clinical Oncology (JCO) , Jg. 29 2011, Nr. 28, S. 3791 – 3797
-
Robotic Surgery in der Gynäkologie - Chirurgie der Zukunft oder teurer PR-Gag? : Eine persönliche BetrachtungIn: Der Gynäkologe , Jg. 44 2011, Nr. 5, S. 401 – 404
-
The impact of dose intensity on the efficacy of gemcitabine plus carboplatin (GC) therapy for recurrent platinum-sensitive ovarian cancer (PSOC) : a retrospective analysis of AGO-OVAR 2.5In: Journal of Clinical Oncology (JCO) , Jg. 29 2011, Nr. 15_suppl, S. 5088
-
The oxygen-sensitive CCN3 protein regulates both, trophoblast migration/invasion and proliferationIn: Placenta , Jg. 32 2011, Nr. 9, S. A61 – A61
-
The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancerIn: Gynecologic Oncology , Jg. 120 2011, Nr. 2, S. 233 – 238
-
Training in bowel and upper abdominal surgery in gynaecological oncology : European Society of Gynecological Oncology (ESGO) statementIn: International Journal of Gynecological Cancer , Jg. 21 2011, Nr. 7, S. 1264 – 1265
-
Abstract P3-02-09: Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Primary Breast Cancer Patients with Circulating Tumor CellsIn: Cancer Research , Jg. 70 2010, Nr. 24, S. P3 – 02
-
Abstract PD02-04: Molecular Profiling of Circulating Tumor Cells in Blood of Metastatic Breast Cancer Patients Indicates Therapy Response and Provides Information on Epithelial Mesenchymal Transition and Tumor Stem Cell MetabolismIn: Cancer Research , Jg. 70 2010, Nr. 24, S. PD02 – 04
-
Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomasIn: Breast Cancer Research and Treatment , Jg. 120 2010, Nr. 1, S. 67 – 76
-
Das äußere Genitale der Frau : Pathologische Befunde und initiale BehandlungsschritteIn: Der Urologe , Jg. 49 2010, Nr. 12, S. 1496 – 1502
-
Effect of ibandronate on tumor cells in the bone marrow and in blood in patients with primary breast cancer : A pilot study
IBMS Davos Workshops: Bone Biology & Therapeutics; 14-19 March 2010; Davos, Switzerland,In: Bone: Official Journal of the International Bone and Mineral Society (IBMS) , Jg. 46 2010, Nr. Suppl. 1, S. S38 -
Endokrine Therapie des Endometriumkarzinoms und seiner PräkanzerosenIn: Gynäkologische Endokrinologie , Jg. 8 2010, Nr. 1, S. 17 – 25
-
Follow-up of probably benign lesions (BI-RADS 3 category) in breast MR imagingIn: The Breast Journal , Jg. 16 2010, Nr. 3, S. 297 – 304
-
H1N1 Risikofaktor SchwangerschaftIn: Zeitschrift für Geburtshilfe und Neonatologie , Jg. 214 2010, Nr. 2, S. 48 – 51
-
Impact of disseminated tumor cells in bone marrow on outcome of patients with primary ovarian cancerIn: Journal of Clinical Oncology (JCO) , Jg. 28 2010, Nr. Suppl. 15, S. e15545
-
Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV diseaseIn: Annals of Surgical Oncology , Jg. 17 2010, Nr. 6, S. 1642 – 1648
-
Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS)In: BMC Medical Genetics , Jg. 11 2010, 12DOI (Open Access)
-
Ovarielles Überstimulationssyndrom in einer aneuploiden GraviditätIn: Geburtshilfe und Frauenheilkunde , Jg. 70 2010, Nr. 10, S. 828 – 831
-
Risikoadaptierte Strahlentherapie bei brusterhaltender Therapie des frühen Mammakarzinoms : Aktuelle EntwicklungenIn: Der Gynäkologe , Jg. 43 2010, Nr. 10, S. 848 – 852
-
The CYP1A1 Ile462Val polymorphism and platinum resistance of epithelial ovarian neoplasmsIn: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics , Jg. 18 2010, Nr. 7, S. 343 – 347
-
The XbaI G>T polymorphism of the glucose transporter 1 gene modulates ¹⁸F-FDG uptake and tumor aggressiveness in breast cancerIn: Journal of Nuclear Medicine (JNM) , Jg. 51 2010, Nr. 8, S. 1191 – 1197DOI (Open Access)
-
Association of the AA genotype of the BCL2 (-938C>A) promoter polymorphism with better survival in ovarian cancerIn: The International Journal of Biological Markers (IJBM) , Jg. 24 2009, Nr. 4, S. 223 – 229
-
Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancerIn: Breast Cancer Research , Jg. 11 2009, Nr. 5, R71DOI (Open Access)
-
Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patientsIn: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 36 2009, Nr. 10, S. 1543 – 1550
-
Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse modelIn: Molecular Human Reproduction: MHR , Jg. 15 2009, Nr. 10, S. 633 – 643DOI (Open Access)
-
Screening von psychischen Belastungen bei ersterkrankten Brustkrebspatientinnen : Einsatz von HADS-D und PO-BadoIn: Zeitschrift für Psychosomatische Medizin und Psychotherapie , Jg. 55 2009, Nr. 3, S. 248 – 262
-
The AA genotype of a L1C G842A polymorphism is associated with an increased risk for ovarian cancer.In: Anticancer Research , Jg. 29 2009, Nr. 8, S. 3449 – 3452
-
The haplotype of two FSHR polymorphisms in ovarian cancer : A potential role of ethnology in risk modificationIn: Gynecologic Oncology , Jg. 112 2009, Nr. 3, S. 486 – 489
-
Aquaporin-1-Expression bei invasiven MammakarzinomenIn: Der Pathologe , Jg. 29 2008, Nr. Suppl. 2, S. 357 – 362DOI (Open Access)
-
MR-guided vacuum-assisted breast biopsy with a handheld biopsy system : Clinical experience and results in postinterventional MR mammography after 24 hIn: European Radiology , Jg. 18 2008, Nr. 1, S. 168 – 176
-
Androgenproduzierender Leydig-Zell-Tumor des Ovars als Ursache von Hirsutismus bei einer postmenopausalen FrauIn: Medizinische Klinik , Jg. 102 2007, Nr. 3, S. 259 – 262
-
Das Dilemma des frühen vorzeitigen Blasensprunges : Entbinden oder abwarten?In: Geburtshilfe und Frauenheilkunde , Jg. 67 2007, Nr. 10, S. 1126 – 1131
-
Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancerIn: Gynecologic Oncology , Jg. 107 2007, Nr. 2, S. 331 – 338
-
The AA genotype of the regulatory BCL2 promoter polymorphism (-938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patientsIn: Clinical Cancer Research , Jg. 13 2007, Nr. 19, S. 5790 – 5797DOI (Open Access)
-
The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinomaIn: Breast Cancer Research and Treatment , Jg. 105 2007, Nr. 3, S. 311 – 317
-
Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathwaysIn: Journal of Clinical Pathology: JCP Online , Jg. 59 2006, Nr. 7, S. 685 – 691DOI (Open Access)
-
Relationship and prognostic significance of phospho-(serine 166)-murine double minute 2 and Akt activation in node-negative breast cancer with regard to p53 expressionIn: Virchows Archiv , Jg. 448 2006, Nr. 1, S. 16 – 23
-
Die Magnetresonanztomographie(MRT)-gesteuerte Mamma-Vakuumbiopsie mit dem Vacora®-System : Erste ErgebnisseMR-Guided Vacuum Assisted Breast BiopsyInitial ResultsIn: Zentralblatt für Gynäkologie , Jg. 127 2005, Nr. 6, S. 400 – 406
-
ETV6-NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexualIn: Breast , Jg. 14 2005, Nr. 1, S. 71 – 74
-
Endokrin aktive Ovarialtumoren : vielfältige gewebliche ErscheinungsbilderIn: Essener Unikate: Berichte aus Forschung und Lehre 2005, Nr. 25 : Medizin – Unsere Hormone, S. 76 – 85Online Volltext (Open Access)
-
High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome.In: Breast Cancer Research : BCR , Jg. 7 2005, Nr. 2DOI (Open Access)
-
Prognostic relevance of activated Akt kinase in node-negative breast cancer : A clinicopathological study of 99 casesIn: Modern Pathology , Jg. 17 2004, Nr. 1, S. 15 – 21DOI (Open Access)
-
Rare expression of target antigens for immunotherapy on disseminated tumor cells in breast cancer patients without overt metastasesIn: International Journal of Molecular Medicine , Jg. 12 2003, Nr. 6, S. 969 – 975
-
The LACC Trial and Minimally Invasive Surgery in Cervical CancerIn: Journal of Minimally Invasive Gynecology (JMIG) , Jg. 27 2020, Nr. 2, S. 462 – 463DOI (Open Access)
-
Surgical Treatment Of Vulvar Carcinoma Following The Paradigm Of Ontogenetic Cancer Fields Drastically Reduces Locoregional RelapsesIn: International Journal of Gynecological Cancer , Jg. 35 2025, Nr. 2, Suppl. 1, S. 100422
-
The immune and metabolic phenotype is changed in fetal livers upon systemic sFLT1 expression in preeclamptic mice which is linked to adverse offspring metabolic responsesIn: Journal of Reproductive Immunology , Jg. 159 2023, S. 104036
-
Immunohistochemical expression of the anti-angiogenic VEGF-A splice variant VEGF-A165b as predictive biomarker for bevacizumab treatment in advanced ovarian cancer patients
15. Jahrestagung der Mitteldeutschen Gesellschaft für Frauenheilkunde und Geburtshilfe e.V. (MGFG), 17.-18.06.2022, Halle an der Saale,In: Geburtshilfe und Frauenheilkunde , Jg. 82 2022, Nr. 6: Kongressabstracts zur 15. Jahrestagung der Mitteldeutschen Gesellschaft für Frauenheilkunde und Geburtshilfe e.V. (MGFG), S. E30 – E31 -
Therapeutischer Plasmaaustausch bei schwerer und früh einsetzender Präeklampsie : monozentrische Erfahrung über 7 JahrenIn: Geburtshilfe und Frauenheilkunde , Jg. 82 2022, Nr. 10, S. e95
-
Image-based identification of single circulating tumor cells in ovarian cancer patients for genomic analysis
AACR Annual Meeting 2021, April 10-15, 2021 and May 17-21, 2021, Philadelphia, PA, USA,In: Cancer Research , Jg. 81 2021, Nr. Suppl. 13, 594 -
Survival in advanced-stage ovarian carcinoma with high VEGF-A expression after addition of bevacizumab : Results from the German ICON7 patient cohortIn: International Journal of Gynecological Cancer , Jg. 31 2021, Nr. Suppl. 3, S. A274 – A274DOI (Open Access)
-
Targeted breast surgery : Non-direct approach
2021 ASCO Annual Meeting, 4. - 8. June 2021, virtuell,In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. Suppl. 15, e12602DOI (Open Access) -
Carboplatin/PLD/Bevacizumab als neue Standardtherapieoption beim Ovarialkarzinomspätrezidiv – aktuelle Ergebnisse der AGO OVAR 2.21 StudieIn: Geburtshilfe und Frauenheilkunde , Jg. 80 2020, Nr. 10, S. e91
-
Evaluation der CEACAM-1 Level im Serum von Schwangeren im ersten Trimester bei hohem Risiko für PräeklampsieIn: Geburtshilfe und Frauenheilkunde , Jg. 80 2020, Nr. 10, S. e151
-
Evaluation des Verlaufs von sFlt-1/PlGF bei intrauteriner Wachstumsretardierung ohne und mit PräeklampsieIn: Geburtshilfe und Frauenheilkunde , Jg. 80 2020, Nr. 10, S. e150 – e151
-
Lebendgeburt und Uteruserhalt bei CervixschwangerschaftIn: Geburtshilfe und Frauenheilkunde , Jg. 80 2020, Nr. 10, S. e275
-
Metastatic breast cancer subgroup specific mRNA profiles of circulating tumor cells and extracellular vesicles
AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, USA,In: Cancer Research , Jg. 80 2020, Nr. Suppl. 16, S. 5366DOI (Open Access) -
Sentinel-Lymphnode Biopsy in primary breast cancer : 99mTc versus ICG—A prospective, randomized trial.In: Journal of Clinical Oncology (JCO) , Jg. 38 2020, Nr. 15_Suppl., S. 575DOI (Open Access)
-
Establishment of a workflow for analysis of mRNA and gDNA from circulating tumor cells, extracellular vesicles and cell-free DNA from the same blood sample to mirror the genomic and transcriptomic complexity in metastatic breast cancer patientsIn: Cancer Research , Jg. 79 2019, Nr. Suppl. 13DOI (Open Access)
-
Workflow evaluation for molecular characterization of single circulating tumor cells in blood samples of patients with gynecological malignanciesIn: Cancer Research , Jg. 79 2019, Nr. Suppl. 13DOI (Open Access)
-
Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patients
2017 San Antonio Breast Cancer Symposium ; December 5-9, 2017, San Antonio, Texas,In: Cancer Research , Jg. 78 2018, Nr. 4, Supplement, S. PD3 – 02DOI (Open Access) -
Prediction of post-operative residual disease in advanced-stage ovarian cancer (AOC) using whole transcriptome expression : An exploratory analysis of the AGO-OVAR 11 (ICON7) trialIn: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. Suppl. 15, S. 5550 – 5550DOI (Open Access)
-
Sentinel lymphnode biopsy (SLNB) and targeted axillary surgery (TAS) by indocyaningreen (ICG) and a novel near-infrared color camera system : a prospectively randomised, multicenter study to avoid radioactivity in a time-/cost-saving procedure in primary breast cancer
2017 San Antonio Breast Cancer Symposium ; December 5-9, 2017, San Antonio, Texas,In: Cancer Research , Jg. 78 2018, Nr. 4, Supplement , OT2-01-05DOI (Open Access) -
Serum levels of RANKL are increased in primary breast cancer patients in the presence of disseminated tumor cells in the bone marrow
2018 Annual Meeting of the American Society for Bone and Mineral Research Palais des congrès de Montréal in Montréal, Quebéc, Canada September 28 – October 1, 2018,In: Journal of Bone and Mineral Research (JBMR) , Jg. 33 2018, Nr. Suppl. 1, S. 72 – 73 -
Significant overall survival improvement in proliferative subtype ovarian cancer patients receiving BevacizumabIn: International Journal of Gynecological Cancer , Jg. 28 2018, Nr. Suppl. 2, S. 51DOI (Open Access)
-
Significant overall survival improvement in proliferative subtype ovarian cancer patients receiving bevacizumabIn: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. 15_suppl, S. 5520 – 5520DOI (Open Access)
-
Similarities and differences in RNA profiles of circulating tumor cells in breast cancer subtypes : Do we have therapeutic options?
2017 San Antonio Breast Cancer Symposium ; December 5-9, 2017, San Antonio, Texas,In: Cancer Research , Jg. 78 2018, Nr. 4, Supplement , P2-01-06DOI (Open Access) -
ERCC1-Expressinf Circulating Tumor Cells as a Potential Diagnostic Tool for Monitoring Platinum-Based Chemotherapy and for Predicting Outcome of Ovarian CancerIn: International Journal of Gynecological Cancer , Jg. 27 2017, Nr. Suppl. 4, S. ESGO7 – 0140
-
Analysis of disseminated tumor cells before and after platinum-based chemotherapy in primary ovarian cancer : Do stem cell like cells predict prognosis?
Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,In: Oncology Research and Treatment , Jg. 39 2016, Nr. Suppl. 1, S. 22 -
Association between tumor infiltrating immune cells and disseminated tumor cells in the bone marrow of patients with primary breast cancer : A ten year follow-upIn: Cancer Research , Jg. 76 2016, Nr. 4 Suppl. , P4-04-07
-
Circulating U2 small nuclear RNA fragments as a novel diagnostic tool for patients with epithelial ovarian cancer
Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,In: Oncology Research and Treatment , Jg. 39 2016, Nr. Suppl. 1, S. 95 – 96 -
ICG-guided prparation of the mullerian lymphatic network in robotic ontogenetically based radical uterine cancer surgery - a video guideIn: International Journal of Gynecological Cancer , Jg. 26 2016, Nr. Suppl. 3, S. 1193
-
The FNTB-609G > C polymorphism as a possible predictive factor for efficacy of lonafarnib-treatment? : Exploratory analysis of a randomized phase II clinical trial in stage IIb-IV ovarian cancer, treated with first-line platinum-based chemotherapy with or without lonafarnib
Deutsche Gesellschaft für Experimentelle und Klinische Pharmakologie und Toxikologie e.V., 81th Annual Meeting, March 10 - 12, 2015, Kiel, Germany,In: Naunyn-Schmiedeberg's Archives of Pharmacology , Jg. 388 2015, Nr. Suppl. 1, S. 52 -
AGO-OVAR 12 : A Randomized Placebo-controlled GCIG/ENGOT-Intergroup Phase III trial of standard frontline chemotherapy plus /- Nintedanib for advanced ovarian cancer
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 1, S. 74 – 75 -
Independent review of AGO-OVAR 12, a GCIG/ENGOT-Intergroup phase III trial of nintedanib (N) in first-line therapy for ovarian cancer (OC)In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15, suppl., S. 5556
-
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsIn: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 1: 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 19DOI (Open Access)
-
The detection of excision repair cross-complementing rodent repair deficiency, complementation group 1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum-resistance
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 1, S. 3 -
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastastic breast cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Oncology Research and Treatment , Jg. 36 2013, Nr. Suppl. 7, S. 157 -
The haplotype of three polymorphisms in the SATB1 promoter-region and impact on survival in breast cancer patientsIn: Journal of Clinical Oncology (JCO) , Jg. 31 2013, Nr. 15 Suppl., S. 584
-
The role of excision repair cross-complementation 1 enzyme (ERCC1)-positive circulating tumor cells in primary and metastatic breast cancerIn: Cancer Research , Jg. 73 2013 , P1-04-13
-
Regulation of placental connexins 43 and 46 upon low oxygen and its impact on preeclampsia
International Federation of Placenta Associations Meeting 2012, 18 - 21 September 2012, Hiroshima, Japan,In: Placenta , Jg. 33 2012, Nr. 9, S. A86 – A86 -
Risk-reducing surgery by skin-sparing mastectomy (SSM) and immediate implant-based reconstruction with and without titanized meshes and quality of lifeIn: Journal of Clinical Oncology (JCO) , Jg. 30 2012, Nr. 27_suppl, S. 48 – 48
-
The CCN3 protein : Regulator of trophoblast proliferation and migration/invasion, and its contribution to preeclampsiaIn: Journal of Reproductive Immunology , Jg. 94 2012, Nr. 1, S. 71
-
The effect of oxygen on placental connexins 43 and 46 and its contribution to preeclampsia
joint International Congress of the American Society for Reproductive Immunology (ASRI) & the European Society for Reproductive Immunology (ESRI), May 31 - June 2, 2012, Hamburg, Germany,In: Journal of Reproductive Immunology , Jg. 94 2012, Nr. 1, S. 34 – 35 -
Triple-negative breast cancer (TNBC) and residual disease (non-pCR) : Does size matter?In: Journal of Clinical Oncology (JCO) , Jg. 30 2012, Nr. 27_Suppl, S. 106
-
Are mesothelin and L1CAM useful biomarkers in primary ovarian cancer patients?In: Journal of Clinical Oncology (JCO) , Jg. 29 2011, Nr. 15, Suppl., S. e15559
-
CK-19, MAGE-A3, HER-2 and TWIST-1 expression by RT-qPCR in CTCs of primary breast cancer patients after positive immune-magnetic selection using anti-EpCAM and anti-MUC1 magnetic beadsIn: Cancer Research , Jg. 71 2011, Nr. 8, Suppl., S. 4150
-
Primary tumor loss of heterozygosity proximal to M6P/IGF2R locus is predictive for the presence and persistence of disseminated tumor cells in the bone marrow of ovarian cancer patientsIn: Cancer Research , Jg. 71 2011, Nr. 8, Suppl., S. 2217
-
Are bisphosphonate ibandronate influence disseminated tumor cells in the bone marrow and circulating blood tumor cells in patients with primary breast cancers? Presentation of a pilot studyIn: Onkologie , Jg. 33 2010, Nr. Suppl.2, S. 38 – 38
-
Primary systemic chemotherapy with carboplatin AUC 6 and docetaxel 75 mg/m2 (q3w) in triple-negative early breast cancer
2010 ASCO Annual Meeting, June 4-8, 2010, Chicago, Ill., USA,In: Journal of Clinical Oncology (JCO) , Jg. 28 2010, Nr. Suppl. 15, e11063 -
The role of CCN3 (NOV) on migratory and invasive properties of trophoblast cellsIn: European Journal of Cell Biology (EJCB) , Jg. 89 2010, Nr. Suppl. 60, S. 11 – 11
-
The role of minimal invasive techniques for the management of ovarian tumoursIn: Ovarian Cancer: The "Gynaecological Challenge?: From Diagnostic Work-Up to Cytoreduction and Chemotherapy / Iavazzo, Christos (Hrsg.) , Jg. 2 2024, S. 35 – 42
-
Treatment of recurrent ovarian cancerIn: Ovarian Cancer: The "Gynaecological Challenge?: From Diagnostic Work-Up to Cytoreduction and Chemotherapy / Iavazzo, Christos (Hrsg.) , Jg. 2 2024, S. 265 – 274
-
Molecular Characterization of Single Circulating Tumor Cells in Breast and Ovarian CancerIn: Circulating Tumor Cells / Cote, Richard J.; Lianidou, Evi (Hrsg.) 2023, S. 327 – 358
-
Robotic-assisted radical hysterectomy as compartmental resection according to rTMMR and rPMMRIn: Hysterectomy: A Comprehensive Surgical Approach / Alkatout, Ibrahim; Mettler, Liselotte (Hrsg.) 2018, S. 921 – 932
-
Robotically Assisted Therapeutic Pelvic and Paraaortic Lymphadenectomy in Uterine CancerIn: Hysterectomy: A Comprehensive Surgical Approach / Alkatout, Ibrahim; Mettler, Liselotte (Hrsg.) 2018, S. 933 – 945
-
Basic principles of dose intensity and high-dose chemotherapyIn: Chemotherapy for Gynecological Neoplasms: Current Therapy and Novel Approaches / Angioli, Roberto (Hrsg.) 2004, S. 57 – 65
-
A clustering and mutual information based analysis of the ELIMA study results : The additive value of multi-parametric liquid biopsies, including CTCs, EVs and cfDNA, in metastatic breast cancer
San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas,In: Cancer Research , Jg. 81 2021, Nr. 4, Supplement, S. PS6 – 60DOI (Open Access) -
Dynamics of a multi-parametric liquid biopsy, including CTCs, EVs, and cfDNA, during therapy in metastatic breast cancer patients provide useful insights for therapy management
San Antonio Breast Cancer Virtual Symposium ; December 8-11, 2020; San Antonio, Texas,In: Cancer Research 2021, S. PS2 – 24DOI (Open Access) -
Natural transition targeted surgery
San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas,In: Cancer Research , Jg. 81 2021, Nr. 4, Supplement, S. PS1 – 11DOI (Open Access) -
The effect of oxygen on placental connexins 43 and 46 and its contribution to preeclampsia
International Federation of Placenta Associations Meeting 2011, 14 - 17 September 2011, Geilo, Norway,In: Placenta , Jg. 32 2011, Nr. 9, S. A86 -
Optimierung des Therapiemanagements gynäkologischer Malignome durch interdisziplinäre und intersektorale Online-Tumorkonferenzen : Ein Projekt der integrierten Versorgung und Versorgungsforschung
Strukturen verändern - Heilung verbessern ; 29. Deutscher Krebskongress ; 24.-27. Februar 2010, Berlin,In: Oncology Research and Treatment , Jg. 33 2010, Nr. Suppl. 2, S. 47 – 48 -
Validity of Bone Marker Measurements for Monitoring Response to Bisphosphonate (BP) Therapy with Zoledronic Acid (ZOL) in Metastatic Breast Cancer (mBC) : Useful or Not?
Thirty-Third Annual CTRC‐AACR San Antonio Breast Cancer Symposium, Dec 8‐12, 2010, San Antonio, TX, USA,In: Cancer Research , Jg. 70 2010, Nr. 24, Supplement, P2-09-33 -
Minimal-invasive computerassistierte Chirurgie in der Gynäkologie
Die kleine Form, 25. Oktober 2017, Essen,2017 (Die kleine Form 2017/2018)